Figure 1.
Monoallelic Becn1 loss results in KRT6 upregulation in mammary epithelial cells and tissues. (A) Microarray analysis was performed on samples (three each) of Becn1+/+ and Becn1+/− apoptosis-competent and apoptosis-defective iMMECS, as well as mammary tumors derived from orthotopic implantation of apoptosis-defective iMMECs in nude mice. KRT6 expression relative to that in apoptosis-competent Becn1+/+ iMMECs is presented as means ± SDs (n = 3). (B–D) Becn1+/+ (left) and Becn1+/− (right) with DAPI (blue) by IF: (B) More KRT6-expressing cells are seen in Becn1+/− apoptosis-competent iMMECs (top) and Becn1+/− apoptosis-defective iMMECs (bottom) under normal growth conditions. (C) More KRT6-expressing (green, top) and KRT14-expressing (red, bottom) cells are seen in allograft mammary tumors generated by Becn1+/− apoptosis-defective iMMECs. (D) MGs from 5-wk-old (top) and 9-mo-old (bottom) Becn1+/− mice reveals increased number of KRT6-positive (green) cells that are not KRT8-positive (red). (E) Costaining for KRT6 (purple), CD24 (red), CD29 (green) in MGs from 9-mo-old Becn1+/− mice reveals that KRT6-positve cells colocalize with mammary progenitor cell markers. Scale bar: (B and D) 30 μm; (C and E) 37.5 μm.